Skip to content

Clinical trials

Suspended Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Suspended Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20092
20121
20142
20162
20175
20181
20195
20204
20215
20223
20232
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Suspended43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Mayo Clinic2
National Guard Health Affairs2
Academic and Community Cancer Research United1
Ascentage Pharma Group Inc.1
Bellicum Pharmaceuticals1
DNAtrix, Inc.1
Diagnostic Photonics, Inc.1
Envita Medical Center, Inc.1
European University Miguel de Cervantes1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms43
Colorectal Neoplasms3
Lung Neoplasms3
Neoplasms3
Prostatic Neoplasms3
Carcinoma, Intraductal, Noninfiltrating2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Colonic Neoplasms2
Melanoma2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.